France and Australia double Global Fund contributions:
This article was originally published in Clinica
France and Australia are among the latest countries to answer calls from the Global Fund to Fight AIDS, Malaria and Tuberculosis for the world's wealthier countries to increase their contributions. France has pledged to "significantly increase" its contributions in 2006 rising to Euro300m (US$376m) by 2007 - thereby doubling the amount it contributed in each of 2004 and 2005. Australia too has pledged to double its commitment, allocating a further Aus$50m (US$39m) over three years. The pledges come ahead of last week's so-called replenishment conference in Rome. The event will seek to drum up international support for the organisation in the run-up to a final conference in London in September 2005, as it faces challenging funding targets. Current commitments stand at US$2.3bn in 2005, US$3.5bn in 2006 and US$3.6bn in 2007.
You may also be interested in...
Officials from the US Food and Drug Administration cited their reasons for refusing to review new applications for companies with unresolved data integrity failures.
However, Vaccinex sees possible efficacy for SEMA4D inhibition in later-stage Huntington’s as well as Alzheimer’s disease. Pepinemab is also being studied with Keytruda in head-and-neck cancer.
In last year’s acquisition, Bristol Myers Squibb agreed to pay Celgene investors another $9 per share based on three approvals, including idecabtagene vicleucel (bb2121) by 30 March 2021.